Analyst Recommendations

H.C. Wainwright analyst issues UNDERPERFORM recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Underperform.CPRX was trading at $16.38 at issue of the...

June 3, 2024   CPRX -0.53%

BMO Capital analyst issues OUTPERFORM recommendation for GROY on June 3, 2024 09:32AM ET. GROY was trading at $1.66 at issue of the analyst recommendation.The overall analyst consensus...

June 3, 2024   GROY -0.78%

BMO Capital analyst issues MARKET PERFORM recommendation for PATH on June 3, 2024 09:27AM ET. The previous analyst recommendation was Market Perform.PATH was trading at $11.68 at issue...

June 3, 2024   PATH 12.56%

HSBC analyst issues HOLD recommendation for MDB on June 3, 2024 09:55AM ET. MDB was trading at $242.53 at issue of the analyst recommendation.The overall analyst consensus :...

June 3, 2024   MDB 0.22%

Keefe, Bruyette & Woods analyst issues OUTPERFORM recommendation for MDB on June 3, 2024 09:55AM ET. MDB was trading at $242.53 at issue of the analyst recommendation.The overall...

June 3, 2024   MDB 0.22%

Wedbush analyst issues MARKET PERFORM recommendation for OKTA on June 3, 2024 10:00AM ET. The previous analyst recommendation was Market Perform.OKTA was trading at $89.96 at issue of...

June 3, 2024   OKTA 0.44%

UBS analyst issues UNDERPERFORM recommendation for OKTA on June 3, 2024 10:00AM ET. The previous analyst recommendation was Underperform.OKTA was trading at $89.96 at issue of the analyst...

June 3, 2024   OKTA 0.44%

Oppenheimer analyst issues BUY recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Buy.CPRX was trading at $16.38 at issue of the analyst...

June 3, 2024   CPRX -0.53%

Oppenheimer analyst issues BUY recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Buy.CPRX was trading at $16.38 at issue of the analyst...

June 3, 2024   CPRX -0.53%

H.C. Wainwright analyst issues UNDERPERFORM recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Underperform.CPRX was trading at $16.38 at issue of the...

June 3, 2024   CPRX -0.53%